RT Journal Article
SR Electronic
T1 A Computational Model for Estimating the Progression of COVID-19 Cases in the US West and East Coasts
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.24.20043026
DO 10.1101/2020.03.24.20043026
A1 Yao-Yu Yeo
A1 Yao-Rui Yeo
A1 Wan-Jin Yeo
YR 2020
UL http://medrxiv.org/content/early/2020/03/31/2020.03.24.20043026.abstract
AB The ongoing coronavirus disease 2019 (COVID-19) pandemic is of global concern and has recently emerged in the US. In this paper, we construct a stochastic variant of the SEIR model to make a quasi-worst-case scenario prediction of the COVID-19 outbreak in the US West and East Coasts. The model is then fitted to current data and implemented using Runge-Kutta methods. Our computation results predict that the number of new cases would peak around mid-April 2000 and begin to abate by July, and that the number of cases of COVID-19 might be significantly mitigated by having greater numbers of functional testing kits available for screening. The model also showed how small changes in variables can make large differences in outcomes and highlights the importance of healthcare preparedness during pandemics.Author Summary Coronavirus disease 2019 (COVID-19) has escalated into a global pandemic and has recently emerged in the US. While some countries have managed to contain COVID-19 efficiently, other countries previously thought to have been well-prepared for outbreaks due to higher living standards and healthcare quality have witnessed an unexpected number of cases. It is currently unclear how the US can cope with the COVID-19 pandemic, especially after mishaps during the initial stages. Our study combines conditions unique to the US and transmission dynamics in regions affected most by COVID-19 to produce a quasi-worse-case scenario of COVID-19 in the US and shows the importance of healthcare preparedness during pandemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for the study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are available publicly from Kaggle and CDC.